Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
01 2Omgene Life Sciences Pvt. Ltd
02 2Polfa Tarchomin
03 2Adcock Ingram
04 2Apotex Inc
05 15Astellas Pharma
06 3Baxter Healthcare Corporation
07 2Biocon
08 2Endo International
09 2Fresenius Kabi USA
10 2Hansoh Pharma
11 2Health Biotech
12 4Hikma Pharmaceuticals
13 2Juno Pharmaceuticals Pty Ltd
14 1Kaliberr Labs
15 2Meitheal Pharmaceuticals
16 2Omega Laboratories Limited
17 2Polifarma
18 2Qilu Pharmaceutical
19 2Rajasthan Antibiotics
20 2Sun Pharmaceutical Industries Limited
21 2Teva Pharmaceutical Industries
22 1Themis Medicare
23 2Xellia Pharmaceuticals ApS
24 2Zydus Pharmaceuticals
01 2Dry Sub
02 1INJECTABLE; INJECTION
03 20INJECTABLE;INTRAVENOUS
04 4Injection
05 2Lyophilised Injection
06 1Micafungin 100Mg 10Ml 1 Units Parenteral Use
07 1Micafungin 50Mg 10Ml 1 Units Parenteral Use
08 6POI
09 8POWDER FOR SOLUTION
10 4POWDER;INTRAVENOUS
11 2PULVER TILL INFUSIONSVÄTSKA, LÖSNING
12 2Powder for Infusion Solution
13 2Powder for Solution for IV Infusion
14 2Powder for infusion fluid, resolution
15 3SOLUTION;INTRAVENOUS
16 2Vial
01 4DISCN
02 2Dossier Availability: Q3 2024
03 4Generic
04 2Originator
05 8Prescription
06 23RX
07 19Blank
01 1LEVUSPOZ 100
02 1LEVUSPOZ 50
03 4MICAFUNGIN
04 1MICAFUNGIN 100 mg ADCO
05 1MICAFUNGIN 50 mg ADCO
06 3MICAFUNGIN IN SODIUM CHLORIDE 0.9%
07 18MICAFUNGIN SODIUM
08 6MICAFUNGIN SODIUM FOR INJECTION
09 1MICATHEM
10 5MYCAMINE
11 8Mycamine
12 1Mycamine 100
13 1Mycamine 50
14 11Blank
01 8Canada
02 8India
03 2Italy
04 2Norway
05 2Poland
06 6South Africa
07 2Sweden
08 2Switzerland
09 2Turkey
10 28USA
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Infusion Solution
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Infusion Solution
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MICAFUNGIN SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 50MG BASE/VIAL
Packaging :
Approval Date : 2020-11-05
Application Number : 208366
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MICAFUNGIN SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 2020-11-05
Application Number : 208366
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYCAMINE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 50MG BASE/VIAL
Packaging :
Approval Date : 2005-03-16
Application Number : 21506
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYCAMINE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 2006-06-27
Application Number : 21506
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : MYCAMINE
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 21754
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MICAFUNGIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 50MG BASE/VIAL
Packaging :
Approval Date : 2021-06-16
Application Number : 212156
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MICAFUNGIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 2021-06-16
Application Number : 212156
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MICAFUNGIN SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 50MG BASE/VIAL
Packaging :
Approval Date : 2019-05-17
Application Number : 207344
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MICAFUNGIN SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 2019-05-17
Application Number : 207344
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MICAFUNGIN SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 50MG BASE/VIAL
Packaging :
Approval Date : 2021-07-09
Application Number : 213363
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MICAFUNGIN SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 50MG BASE/VIAL
Packaging :
Approval Date : 2021-07-09
Application Number : 213261
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MICAFUNGIN SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 2021-07-09
Application Number : 213261
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MICAFUNGIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 50MG BASE/VIAL
Packaging :
Approval Date : 2021-07-30
Application Number : 212125
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MICAFUNGIN
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 2021-07-30
Application Number : 212125
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MICAFUNGIN SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 50MG BASE/VIAL
Packaging :
Approval Date : 2021-06-02
Application Number : 211713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MICAFUNGIN SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 2021-06-02
Application Number : 211713
Regulatory Info : RX
Registration Country : USA
